Healthcare M&A in 2025 was shaped by disciplined capital deployment, increased regulatory scrutiny, and heightened focus on reimbursement and operating risk. Against this backdrop, our Healthcare M&A, Joint Ventures, and Other Transactions team advised buyers and sellers across the care continuum on more than 125 transactions last year.
Our highlights what’s driving deal activity—from how transactions were structured to the issues most likely to influence timing, risk, and execution. Explore the report for practical, deal-driven insights drawn from sponsor-backed and strategic healthcare transactions nationwide.